Unique Patterns of Allelic Imbalance Distinguish Type 1 from Type 2 Sporadic Papillary Renal Cell Carcinoma

Por Sanders, Melinda E., Mick, Rosemarie, Tomaszewski, John E., Barr, Frederic G.
Publicado em 2002

A Molecular Analysis of Tumor Margins by MALDI Mass Spectrometry in Renal Carcinoma

Por Oppenheimer, Stacey R., Mi, Deming, Sanders, Melinda E., Caprioli, Richard M.
Publicado em 2010

Proteomics in Diagnostic Pathology: Profiling and Imaging Proteins Directly in Tissue Sections

Por Chaurand, Pierre, Sanders, Melinda E., Jensen, Roy A., Caprioli, Richard M.
Publicado em 2004

Drug response in organoids generated from frozen primary tumor tissues

Por Walsh, Alex J., Cook, Rebecca S., Sanders, Melinda E., Arteaga, Carlos L., Skala, Melissa C.
Publicado no Sci Rep (2016)

Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow up

Por Sanders, Melinda E., Schuyler, Peggy A., Simpson, Jean F., Page, David L., Dupont, William D.
Publicado no Mod Pathol (2014)

Establishing the Clinical Utility of Autofluorescence Spectroscopy for Parathyroid Detection

Por McWade, Melanie A., Sanders, Melinda E., Broome, James T., Solórzano, Carmen C., Mahadevan-Jansen, Anita
Publicado no Surgery (2015)

Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer

Por Walsh, Alex J., Cook, Rebecca S., Sanders, Melinda E., Aurisicchio, Luigi, Ciliberto, Gennaro, Arteaga, Carlos L., Skala, Melissa C.
Publicado em 2014

A Phyllodes-like Mammary Tumor in a Breeding Galago (Otolemur garnettii)

Por Jones, Carissa P, Apple, Troy M, Burton, Bryce J, Sanders, Melinda E, Boyd, Kelli L, Salleng, Kenneth J
Publicado no Comp Med (2016)

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Por Lehmann, Brian D., Bauer, Joshua A., Chen, Xi, Sanders, Melinda E., Chakravarthy, A. Bapsi, Shyr, Yu, Pietenpol, Jennifer A.
Publicado em 2011

Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy

Por Atuegwu, Nkiruka C, Arlinghaus, Lori R, Li, Xia, Chakravarthy, A Bapsi, Abramson, Vandana G, Sanders, Melinda E, Yankeelov, Thomas E
Publicado em 2013

HISTOLOGIC ASSOCIATIONS AND LONG-TERM CANCER RISK IN COLUMNAR CELL LESIONS OF THE BREAST: A RETROSPECTIVE COHORT AND A NESTED CASE-CONTROL STUDY

Por Boulos, Fouad I, Dupont, William D, Simpson, Jean F, Schuyler, Peggy A, Sanders, Melinda E, Freudenthal, Marcia E, Page, David L
Publicado em 2008

Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

Por Muraoka, Rebecca S., Koh, Yasuhiro, Roebuck, L. Renee, Sanders, Melinda E., Brantley-Sieders, Dana, Gorska, Agnieszka E., Moses, Harold L., Arteaga, Carlos L.
Publicado em 2003

Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk

Por Dupont, William D., Breyer, Joan P., Bradley, Kevin M., Schuyler, Peggy A., Plummer, W. Dale, Sanders, Melinda E., Page, David L., Smith, Jeffrey R.
Publicado em 2010

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Por Lehmann, Brian D., Jovanović, Bojana, Chen, Xi, Estrada, Monica V., Johnson, Kimberly N., Shyr, Yu, Moses, Harold L., Sanders, Melinda E., Pietenpol, Jennifer A.
Publicado no PLoS One (2016)

Precision of Multiple Reaction Monitoring Mass Spectrometry Analysis of Formalin-Fixed, Paraffin-Embedded Tissue

Por Sprung, Robert W., Martinez, Misti A., Carpenter, Kristen L., Ham, Amy-Joan L., Washington, Mary Kay, Arteaga, Carlos L., Sanders, Melinda E., Liebler, Daniel C.
Publicado em 2012

Differentiating Proteomic Biomarkers in Breast Cancer by Laser Capture Microdissection and MALDI MS

Por Sanders, Melinda E., Dias, Eduardo C., Xu, Baogang J., Mobley, James A., Billheimer, Dean, Roder, Heinrich, Grigorieva, Julia, Dowsett, Mitchell, Arteaga, Carlos L., Caprioli, Richard M.
Publicado em 2008

Discordant cellular response to pre-surgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification

Por Balko, Justin M., Mayer, Ingrid A., Sanders, Melinda E., Miller, Todd W., Kuba, Maria G., Meszoely, Ingrid M., Wagle, Nikhil, Garraway, Levi A., Arteaga, Carlos L.
Publicado em 2012

Estrogen Metabolism and Exposure in a Genotypic-Phenotypic Model for Breast Cancer Risk Prediction

Por Crooke, Philip S., Justenhoven, Christina, Brauch, Hiltrud, Dawling, Sheila, Roodi, Nady, Higginbotham, Kathryn S. P., Plummer, W. Dale, Schuyler, Peggy A., Sanders, Melinda E, Page, David L., Smith, Jeffrey R., Dupont, William D., Parl, Fritz F.
Publicado em 2011

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Por Lehmann, Brian D, Bauer, Joshua A, Schafer, Johanna M, Pendleton, Christopher S, Tang, Luojia, Johnson, Kimberly C, Chen, Xi, Balko, Justin M, Gómez, Henry, Arteaga, Carlos L, Mills, Gordon B, Sanders, Melinda E, Pietenpol, Jennifer A
Publicado em 2014

Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer

Por Dennison, Jennifer B., Molina, Jennifer R., Mitra, Shreya, González-Angulo, Ana M., Balko, Justin M., Kuba, María G., Sanders, Melinda E., Pinto, Joseph A., Gómez, Henry L., Arteaga, Carlos L., Brown, Robert E., Mills, Gordon B.
Publicado em 2013